Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity

Anticancer Research

Volumn 18, Issue 2 B, 1998, Pages 1341-1344

  Miret, Carlos ^a   Font, Josep ^a   Molina, Rafael ^a   Filella, Xavier ^a   Vivancos, Josep ^a   Muñoz Rodriguez, Francisco J ^a   Cervera, Ricard ^a   Ballesta, Antonio M ^a   Ingelmo, Miguel ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

CA 125 tumor markers; SCC; Systemic lupus erythematosus

Indexed keywords

CA 125 ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGENS, NEOPLASM; CA-125 ANTIGEN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEPHROTIC SYNDROME; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031858997     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Steinberg AD: Systemic lupus erythematosus: theories of pathogenesis and approach to therapy. Clin Immunol Immunopathol 72: 171-176, 1994.
2. Spronk PE, Borj EJ, Huitema MG, Limburg PC, Hallemberg CGM: Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD, in relation to disease exacerbations in patients with systemic lupus erythematosus. A prospective study. Ann Rheum Dis: 53: 235-239, 1994.
3. Font J, Pallares L, Martorell J, Martinez E, Gaya A, Vives J, Ingelmo M: Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus. Clin Immunol Immunopathol 81: 239-243, 1996.
4. Moncayo R, Moncayo H: Serum levels of CA 125 are elevated in patients with active systemic lupus erythematosus. Obstet Gynecol 77: 932-934, 1991.
5. Moncayo R, Moncayo H: A new endocrinological and immunological syndrome in SLE: elevation of human chorionic gonadotropin and of antibodies directed against ovary and endometrium antigens. Lupus 4: 39-45, 1995.
6. Kato H, Torigoe T: Radioimmunoassay for tumor antigen of human servical squamous cell carcinoma. Cancer 41: 1621-1628, 1977.
7. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH and the committee on prognosis studies in SLE: Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35: 630-640, 1992.
8. Cases A, Filella X, Molina R, Ballesta A, López-Pedret J, Revert Ll: Tumor markers in chronic renal failure and hemodialysis patients. Nephron 57: 183-186, 1991.
9. Molina R, Filella X, Bruix J, Mengual P, Bosch J, Calvet X et al: Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem 37: 1379-1383, 1991.
10. Molina R, Ojeda B, Filella X, Boiras G, Jo J, Mas E, Lopez JJ, Ballesta A: A prospective study oftumor markers CA 125 and CA 19.9 in patients with epithelial ovarian carcinomas. Tumor Biol 13: 278-286, 1992.
11. Ricolleau G, Chatal JF, Fumoleau P, Kremer M, Douillard JY, Curtet C: Radioimmunoassay of the CA-125 antigen in ovarian carcinomas: advantages compared with CA 125 and CEA. Tumor Biol 5: 151-159, 1984.
12. Kruitwagen R, Koster A, Thomas C, Willemsen W, Poels L, Rolland R: High CA 125 concentrations in peritoneal fluid of normal cyclic women with various infertility-related factors as demostrated with two-step immunoradiometric assay. Fertil Steril 56: 863-869, 1991.
13. Trimble E, Saigo P, Freeberg G, Rubin S, Hoskins W: Peritoneal sarcoidosis and elevated CA 125. Obstet Gynecol 78: 976-977, 1991.
14. Imai A, Itoh T, Niwa K, Tamaya T: Elevated CA 125 serum levels in a patient with tuberculous peritonitis. Arch Gynecol Obstet 248: 157-159, 1991.
15. Calls J, Cases A, Filella X, Molina R, Revert L, Ballesta AM: Increased serum levels of CA 125 in patients with nephrotic syndrome. Nefrologia 13: 127-130, 1993.
16. Cacoub P, Le Thi Huong DU, Wechsler B, Chapelon C, Auperin A, Gandjbakch I et al: Pericardite chronique constrictive responsable d'une elevation du CA 125. Deux observations. Presse Med 19: 1712-1714, 1990.
17. Kato H, Torigoe T: Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 41: 1621-1628, 1977.
18. Ueda G, Inove Y, Yamasaki M et al: Immunohistochemical demonstration of tumor antigen Ta-4 in gynecologic tumors. Int J Gynecol Pathol 3: 291-296, 1984.
19. Molina R, Filella X, Torres MD, Ballesta AM, Mengual P, Cases A et al: SCC antigen measured in malignant and nonmalignant diseases. Clin Chem 36: 251-254, 1990.
20. Molina R, Ballesta AM, Filella X, Santabarbara P, Borras G, Balaque A: Evaluation of a new tumor marker. SCC. Tumor Biol 8: 327, 1987.
21. Molina R, Torres MD, Filella X, Mengual PJ, Arias C, Ballesta AM: Serum SCC antigen in patients with head and neck tumors. J Tumor Marker Oncol 2: 277-282, 1987.